CorMedix, Inc. (CRMD)
8.26
-0.04
(-0.48%)
USD |
NASDAQ |
Aug 31, 16:00
8.20
-0.06
(-0.73%)
After-Hours: 07:17
CorMedix Total Long Term Debt (Quarterly) : 145.15M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 145.15M |
| March 31, 2026 | 144.88M |
| December 31, 2025 | 148.06M |
| September 30, 2025 | 3.548M |
| June 30, 2025 | 0.2581M |
| March 31, 2025 | 0.3041M |
| December 31, 2024 | 0.3491M |
| September 30, 2024 | 0.393M |
| June 30, 2024 | 0.4352M |
| March 31, 2024 | 0.4766M |
| December 31, 2023 | 0.517M |
| September 30, 2023 | 0.5564M |
| June 30, 2023 | 0.5943M |
| March 31, 2023 | 0.6314M |
| December 31, 2022 | 0.6676M |
| September 30, 2022 | 0.7029M |
| June 30, 2022 | 0.7369M |
| March 31, 2022 | 0.77M |
| December 31, 2021 | 0.8024M |
| September 30, 2021 | 0.834M |
| June 30, 2021 | 0.8643M |
| March 31, 2021 | 0.8943M |
| December 31, 2020 | 0.9237M |
| September 30, 2020 | 0.9523M |
| June 30, 2020 | 0.0018M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0023M |
| December 31, 2019 | 0.0027M |
| September 30, 2019 | 0.0031M |
| June 30, 2019 | 6.738M |
| March 31, 2019 | 6.431M |
| December 31, 2018 | 6.125M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 8.671M |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Innoviva, Inc. | 268.94M |
| Zevra Therapeutics, Inc. | 0.87M |
| Filana Therapeutics, Inc. | 0.00 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |